PRESS RELEASE published on 04/16/2024 at 07:45, 7 months 5 days ago Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets Marinomed Biotech AG announces 2023 financial year results, highlighting progress with Marinosolv and Carragelose assets. Focus on achieving operating profitability and commercialization 2023 Financial Year Operating Profitability Marinomed Biotech AG Marinosolv Carragelose Assets
BRIEF published on 04/11/2024 at 07:50, 7 months 10 days ago Marinomed Biotech AG annonce une double expansion du marché pour les produits à base de carragelose Marinomed Biotech L'expansion Du Marché Carrragélose Spray Nasal Blocage Des Allergènes
BRIEF published on 04/11/2024 at 07:50, 7 months 10 days ago Marinomed Biotech AG Announces Dual Market Expansion for Carragelose Products Carragelose Market Expansion Marinomed Biotech Nasal Spray Allergen-blocking
PRESS RELEASE published on 04/11/2024 at 07:45, 7 months 10 days ago Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico Marinomed Biotech AG expands Carragelose product portfolio with new launches in Austria and Mexico, targeting new indications and key markets Mexico Marinomed Biotech AG Carragelose Allergen-blocking Austria
BRIEF published on 03/28/2024 at 07:50, 7 months 24 days ago Marinomed Biotech AG Secures Loan Repayment Deferral with European Investment Bank Marinomed Biotech AG European Investment Bank Loan Repayment Deferral Marinosolv Platform Carragelose Business Expansion
BRIEF published on 03/28/2024 at 07:50, 7 months 24 days ago Marinomed Biotech AG obtient un report de remboursement de son prêt auprès de la Banque européenne d'investissement Marinomed Biotech AG Banque Européenne D'investissement Report De Remboursement Du Prêt Plateforme Marinosolv Expansion Des Activités De Carragelose
PRESS RELEASE published on 03/28/2024 at 07:45, 7 months 24 days ago Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months Marinomed Biotech AG European Investment Bank Deferral Agreement Marinosolv Platform Venture Loan
BRIEF published on 03/26/2024 at 07:50, 7 months 26 days ago Marinomed Biotech AG étend la distribution de carragelose dans la région du Golfe et en Europe de l'Est VitaPlus Kft Marinomé Carrragélose GAIA Santé Distribution Pharmaceutique
BRIEF published on 03/26/2024 at 07:50, 7 months 26 days ago Marinomed Biotech AG Expands Carragelose Distribution in Gulf Region and Eastern Europe Carragelose Marinomed GAIA Healthcare VitaPlus Kft Pharmaceutical Distribution
PRESS RELEASE published on 03/26/2024 at 07:45, 7 months 26 days ago Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe Marinomed Biotech AG partners with GAIA Healthcare FZ LLC and VitaPlus Kft. to distribute Carragelose nasal sprays in Gulf region and Eastern Europe, expanding market reach Marinomed Biotech AG Carragelose Distribution Partnerships GAIA Healthcare FZ LLC VitaPlus Kft.
Published on 11/21/2024 at 20:15, 33 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 38 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 48 minutes ago Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:25, 1 hour 23 minutes ago Ibero Mining Reports Results From Deep Undercut Drill Hole At Miguel Vacas Mine
Published on 11/21/2024 at 17:35, 3 hours 13 minutes ago 1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 19:01, 1 hour 47 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 2 hours 12 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 2 hours 50 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 2 hours 56 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 2 hours 56 minutes ago LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.
Published on 11/21/2024 at 06:58, 13 hours 50 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 13 hours 50 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 13 hours 50 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 1 hour ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
